Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2024 Earnings Conference Call October 30, 2024 9:00 AM ET
Company Participants
Dave Gancarz – Chief Business and Strategy Officer
Bob Duggan – Chairman and CEO
Maky Zanganeh – CEO and President
Manmeet Soni – COO and CFO
Allen Yang – Chief Medical Officer
Conference Call Participants
Mitchell Kapoor – H. C. Wainwright
Brad Canino – Stifel
Yigal Nochomovitz – Citi
Operator
Good morning. And welcome to Summit Therapeutics’ Q3 2024 Earnings and Update Call. All participants will be in a listen only mode until the question-and-answer portion of the call [Operator Instructions]. Please refer to the company’s Web site for updates. Please note that today’s call is being recorded. After the speakers’ remarks, there will be a question-and-answer session. Thank you.
At this time, I would like to turn the call over to Dave Gancarz, Summit Therapeutics’ Chief Business and Strategy Officer. You may proceed.
Dave Gancarz
Good morning, and thank you for joining us. Our press release was issued earlier this morning and is available on the homepage of our Web site. Our Form 10-Q was also filed earlier this morning and is available on our Web site. Today’s call is being simultaneously webcast and an archived replay will also be made available later today on our Web site, www.smmttx.com. Joining me on the call today is Bob Duggan, our Chairman of the Board and Chief Executive Officer; Dr. Maky Zanganeh, our Chief Executive Officer and President; Manmeet Soni, our Chief Operating Officer and Chief Financial Officer; and Dr. Allen Yang, our Chief Medical Officer. Before we get started with the rest of the call, I would like to note that some of the statements made by our management team today and some responses to questions that we will make may be considered forward looking statements based on our current expectations. Summit cautions that these forward-looking statements are subject to risks
Read the full article here